4.2 Article

Chemopreventive effects of rosmarinic acid on rat colon carcinogenesis

Journal

EUROPEAN JOURNAL OF CANCER PREVENTION
Volume 24, Issue 2, Pages 106-112

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/CEJ.0000000000000055

Keywords

aberrant crypt foci assay; comet assay; rosmarinic acid

Categories

Funding

  1. Sao Paulo Research Foundation (FAPESP), Brazil [2008/02211-0]

Ask authors/readers for more resources

Rosmarinic acid (RA) is a polyphenolic compound that shows a number of interesting biological activities, such as antiapoptotic, antifibrotic, antioxidant, hepatoprotective, antineurodegenerative, and anti-inflammatory properties. The aim of this study was to investigate the ability of RA to prevent 1,2-dimethylhydrazine (DMH)-induced primary DNA damage and aberrant crypt foci (ACF) in Wistar rat colon. The animals were treated by gavage with doses of 4, 8, and 16 mg/kg body weight/day. Next, the animals received a single subcutaneous injection of 40 mg/kg DMH and were killed 4 h later for the evaluation of DNA damage using the comet assay. In addition, two doses of 40 mg/kg DMH were administered weekly for 2 weeks and the animals were killed 2 weeks after the last injection for the evaluation of ACF formation in rat colon. The results showed that RA exerted no genotoxic/carcinogenic effects. Treatment with different doses of RA combined with DMH led to a significant reduction in the extent of DNA damage and in the frequency of ACF compared with animals treated with DMH alone. These findings suggest that RA reduces DNA damage and suppresses the formation of ACF. European Journal of Cancer Prevention 24: 106-112 Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available